Arcus Biosciences, Inc.
Arcus Biosciences, Inc. (RCUS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
rcus · stock forecast · 18 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 18 Wall Street analysts in the past 3 months
Buy
18 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$47.00
Consensus
$31.17
+33.7% upside
Low
$22.00
Median: $30 · Last Close: $23.32
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$31.17
33.7% upside
High Target
$47
101.5%
Low Target
$22
-5.7%
Current Price
$23.32
as of today
Based on analyst price targets, the RCUS stock price prediction for the next 12 months ranges from $22 to $47. The consensus RCUS price forecast of $31.17 implies 33.7% upside from the current price of $23.32.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $23.13 | ↓ 0.82% |
1-day model range: $23.01–$23.25. Peak: $23.25 (-0.82%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $22 | -6.7% |
| 2028 | $21 | -10.5% |
| 2029 | $20 | -12.6% |
| 2030 | $20 | -13.9% |
| 2031 | — | -14.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RCUS · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-11 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2026-05-07 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-04-02 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-05 | Citigroup | Maintains | Buy→Buy |
| 2026-03-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-02 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-02-12 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2026-01-13 | Goldman Sachs | Upgrade ↑ | Neutral→Buy |
| 2026-01-08 | Morgan Stanley | Downgrade ↓ | Overweight→Equal Weight |
| 2025-12-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Arcus Biosciences, Inc. (RCUS) stock. Of the recent 93 rating actions, 2 were upgrades and 2 were downgrades. 18 analysts currently cover RCUS.
Analyst Recommendation Trends
RCUS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$93M
↓ 47.8% YoY
Revenue Next Year
$95M
↑ 2.7% YoY
EPS This Year
$-3.71
EPS Next Year
$-3.44
↓ 7.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast RCUS EPS of $-3.71 for the current fiscal year, based on estimates from 7 analysts. The RCUS revenue forecast is $93M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The RCUS stock forecast is supported by two independent data sources: analyst consensus ratings from 18 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus RCUS price target is $31.17 (+33.7% upside), with an analyst consensus of Buy.
The RCUS short-term stock prediction for tomorrow is $23.13 (-0.82%). The RCUS stock price prediction for 2027 estimates an average of $22. The RCUS stock prediction for 2030 projects a range of $19–$21.
Arcus Biosciences, Inc. trades on NYSE under the ticker RCUS. The RCUS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 83% of covering analysts.
Frequently asked questions
RCUS forecast · 8 questionsAccording to 18 Wall Street analysts, the average 12-month RCUS price target is $31.17, with a high forecast of $47.00 and a low of $22.00. The median price target is shown in the chart above when available. This implies +33.7% potential upside from the current price of $23.32.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.